Your browser doesn't support javascript.
loading
Targeted Therapy with Anlotinib for a Patient with an Oncogenic FGFR3-TACC3 Fusion and Recurrent Glioblastoma.
Wang, Yong; Liang, Dandan; Chen, Jimin; Chen, Huan; Fan, Rui; Gao, Ye; Gao, Yongsheng; Tao, Rongjie; Zhang, Henghui.
Afiliação
  • Wang Y; Departments of Neurosurgery, Shandong Cancer Hospital and Institute Affiliated to Shandong University, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, People's Republic of China.
  • Liang D; Genecast Biotechnology Co., Ltd, Wuxi, People's Republic of China.
  • Chen J; Genecast Biotechnology Co., Ltd, Wuxi, People's Republic of China.
  • Chen H; Genecast Biotechnology Co., Ltd, Wuxi, People's Republic of China.
  • Fan R; Genecast Biotechnology Co., Ltd, Wuxi, People's Republic of China.
  • Gao Y; Department of Neurosurgery, The People's Hospital of ZhangQiu Area, Jinan, People's Republic of China.
  • Gao Y; Department of Pathology, Shandong Cancer Hospital and Institute Affiliated to Shandong University, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, People's Republic of China.
  • Tao R; Departments of Neurosurgery, Shandong Cancer Hospital and Institute Affiliated to Shandong University, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, People's Republic of China.
  • Zhang H; Genecast Biotechnology Co., Ltd, Wuxi, People's Republic of China.
Oncologist ; 26(3): 173-177, 2021 03.
Article em En | MEDLINE | ID: mdl-32949176

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinolinas / Glioblastoma Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinolinas / Glioblastoma Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article